Senotherapy
Senotherapeutic's refers to therapeutic agents/strategies that specifically target cellular senescence.[1] Senotherapeutic's include emerging senolytic/senoptotic small molecules that specifically induce cell death in senescent cells [2] and agents that inhibit the pro-inflammatory senescent secretome.[3] Senescent cells can be targeted for immune clearance, but an ageing immune system likely impairs senescent cell clearance leading to their accumulation.[4] Therefore, agents which can enhance immune clearance of senescent cells can also be considered as senotherapeutic.
References
[edit]- ^ Childs et al. (2015). Cellular senescence in aging and age-related disease: from mechanisms to therapy Nature Medicine ((doi:10.1038/nm.4000))
- ^ Chang J., Wang Y.,Shao L. et al., & Zhou D. (2015). Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nature Medicine doi:10.1038/nm.4010
- ^ Xu et al. (2015). JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age PNAS ((doi: 10.1073/pnas.1515386112))
- ^ Burton and Faragher (2015). Cellular senescence: from growth arrest to immunogenic conversion AGE ((doi:10.1007/s11357-015-9764-2))
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.
Cover photo is available under {{::mainImage.info.license.name || 'Unknown'}} license.
Cover photo is available under {{::mainImage.info.license.name || 'Unknown'}} license.
Credit:
(see original file).
